Land: Irland
Språk: engelsk
Kilde: HPRA (Health Products Regulatory Authority)
LOSARTAN POTASSIUM HYDROCHLOROTHIAZIDE
Laboratorios LICONSA, S.A.
LOSARTAN POTASSIUM HYDROCHLOROTHIAZIDE
50/12.5 Milligram
Film Coated Tablet
Product subject to prescription which may be renewed (B)
Authorised
0000-00-00
PACKAGE LEAFLET: INFORMATION FOR THE USER LOSARTAN POTASSIUM/HYDROCHLOROTHIAZIDE LICONSA 50 MG/12.5 MG FILM-COATED TABLETS LOSARTAN POTASSIUM/HYDROCHLOROTHIAZIDE LICONSA 100 MG/25 MG FILM-COATED TABLETS LOSARTAN POTASSIUM / HYDROCHLOROTHIAZIDE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you . Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. • If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet 1. What Losartan Potassium/Hydrochlorothiazide Liconsa is and what it is used for 2. Before you take Losartan Potassium/Hydrochlorothiazide Liconsa 3. How to take Losartan Potassium/Hydrochlorothiazide Liconsa 4. Possible side effects 5. How to store Losartan Potassium/Hydrochlorothiazide Liconsa 6. Further information 1. WHAT LOSARTAN POTASSIUM/HYDROCHLOROTHIAZIDE LICONSA IS AND WHAT IT IS USED FOR Losartan potassium belongs to a group of medicines called angiotensin-II receptor antagonists. Angiotensin-II is a substance produced in the body which binds to receptors in blood vessels causing them to tighten. This results in an increase in blood pressure. Losartan prevents the binding of angiotensin-II to these receptors, causing the blood vessels to relax which in turn lowers the blood pressure. Hydrochlorothiazide belongs to a group of drugs called diuretics (water tablets). [Losartan Potassium/Hydrochlorothiazide Liconsa 50 mg/12.5 mg]: Losartan Potassium/Hydrochlorothiazide Liconsa is used to treat high blood pressure. Losartan Potassium/Hydrochlorothiazide Liconsa is a suitable alternative for those people who would ot Les hele dokumentet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Losartan Potassium/Hydrochlorothiazide Liconsa 50 mg/12.5 mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 50 mg of losartan potassium, equivalent to 45.76 mg of losartan, and 12.5 mg of hydrochlorothiazide. Excipient: 70.31 mg of lactose monohydrate/film-coated tablet. For a full list of exipients see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet. Round, yellow, film-coated tablet. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the treatment of essential hypertension in patients whose blood pressure is not adequately controlled on hydrochlorothiazide or losartan monotherapy. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Method of administration_ The tablet should be swallowed with a sufficient amount of fluid (e.g. one glass of water). Losartan potassium/Hydrochlorothiazide may be administered with or without food. Where possible, titration with the individual components (i.e. losartan and hydrochlorothiazide) is recommended. When clinically appropriate direct change from monotherapy with losartan 50 mg or hydrochlorothiazide 12.5 mg to the fixed combination may be considered in patients whose blood pressure is not adequately controlled. The usual starting and maintenance dose is 1 tablet once daily for most patients. For patients who do not respond adequately, the dosage may be increased to 2 tablets once daily. The maximum dose is 2 tablets once daily. In general, the antihypertensive effect is attained within three to four weeks after initiation of therapy. _Use in the elderly: _No initial dose adjustment is necessary. Experience is limited in this population. _Use in renal impairment_: No initial dosage adjustment is necessary in patients with mild to moderate rena Les hele dokumentet